SAN LUIS OBISPO, Calif., April 23, 2004 (PRIMEZONE) -- 12 to 20 Plus, Inc. (OTCBB:TTTP) is currently in negotiations with two major European distributors of healthcare products in Italy and Germany.
According to Carol Slavin, President of TTTP: Currently our negotiations are under a non-disclosure agreement with two multi-national companies with major distribution channels throughout all of Europe and the British Isles. We have always thought of ourselves as offering a "global" health and wellness product line and we feel these strategic relationships will greatly impact the company's bottom line.
In expectation of significant corporate growth the company has moved into its new corporate headquarters in San Luis Obispo, Ca. These new expanded facilities will allow us to meet the ever increasing demands for our products.
TTTP first quarter milestones:
-- The Company has introduced its e-commerce site,
www.12to20plus.com, to the marketplace. We feel this site
will translate into millions of dollars in revenues for
the company.
-- The Company hired Michael Smith as COO whose expertise is
E-commerce and Sarbanes/Oxley compliance
-- The Company closed its acquisition of H. Bana Solutions for
natural hair loss, a $300 million annual market serving nearly
50 million women and 100 million men worldwide.
-- The Company acquired the exclusive rights to market
"HydroCap+(tm)," a product created specifically for the
millions of active individuals worldwide participating in
any sport or activity who would benefit physically by adding
HydroCap to their daily regime. Providing rapid rehydration
of lost body fluids and nutrients, this untapped market could be
worth millions of dollars in revenues to the company as we go
forward with distribution.
About 12 to 20 Plus, Incorporated
12 to 20 Plus, Incorporated is a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional formulas and nutraceuticals. One of the company's flagship products, Zit Stick(r), is part of a "spa style" acne therapy system(tm). The market for acne remedies is expected to reach $370 million in 2004. 12 to 20 Plus, Inc. also markets highly effective condition-specific dietary supplements containing the most sophisticated combination of extensively researched nutritional elements available. The products are manufactured by FDA-approved labs and do not contain herbs. Instead, the company utilizes potent pharmaceutical grade "amino acids", important protein constituents that serve as neurotransmitter precursors, membrane stabilizers and enzyme precursors. Some of (NRG) products include Anaplex (tm), the antidepressant drug alternative; VisionKare(tm), an advanced supplement for macular degeneration; ChemoKare(tm), a unique combination of extracts designed to treat the side effects of chemotherapy; QuitSystem(r), a neuronutrient supplementation for recovery from alcohol, drugs and smoking and Hinoki Bana(tm), a treatment for men and women with hair loss problems. Retail sales in the explosive dietary supplement market are expected to hit $21 billion by year 2007, according to Frost & Sullivan reports. www.12to20plus.com.
This release contains forward-looking statements and projections. Such statements and projections are made under the safe harbor provisions of applicable laws and regulations. Any reader should be advised that factors such as development of new capital funding, competition, lack of expert personnel and other factors may materially affect in an adverse manner actual results of operations. Further, any reader of this release should seek competent advice from a registered broker or financial planner prior to investing in shares of the issuer.